Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/16/2003WO2002000166A3 New compounds useful as antibacterial agents
10/16/2003WO2001089527A3 Pharmaceutical composition comprising loratadine and a nasal decongestant
10/16/2003US20030196217 Desaturase genes, enzymes encoded thereby, and uses thereof
10/16/2003US20030196213 Extending the life span of sperm by including an phosphodiesterase enzyme inhibitors; side effect reduction
10/16/2003US20030195548 System and device for preventing restenosis in body vessels
10/16/2003US20030195461 For perioperatively inhibiting tumor cell adhesion and a variety of pain and inflammation at wounds from general surgical procedures including oral/dental procedures
10/16/2003US20030195377 Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
10/16/2003US20030195367 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry
10/16/2003US20030195365 CC-1065 analog synthesis
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195361 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
10/16/2003US20030195360 For therapy of oncoses
10/16/2003US20030195356 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
10/16/2003US20030195353 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo- tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
10/16/2003US20030195352 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders
10/16/2003US20030195345 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195344 A DNA libraries having the vector sequences for coding the membrane receptor proteins, or fusion proteins, for binding the membrane-bound proteins; drug delivery target to specific cell site
10/16/2003US20030195333 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195263 Use of 1,2-decandiol for combating germs causing body odour
10/16/2003US20030195262 Administering acetone therapeutically, applied in a predetermined dosage, preferably with a light abrasive action, to the site of an active viral infection
10/16/2003US20030195261 Administering racemic or optically pure sibutramine metabolite, or a pharmaceutically acceptable salt, solvate, or clathrate for prophylaxis or therapy
10/16/2003US20030195260 Administering R(-) desmethylselegiline in a dosage regimen effective to inhibit, in whole or in part, occurrence or progression of the neoplastic disease or condition
10/16/2003US20030195258 Taxol enhancer compounds
10/16/2003US20030195257 Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity
10/16/2003US20030195256 Inhibitors of nitric oxide synthase
10/16/2003US20030195255 Method for treating hepatic encephalopathies
10/16/2003US20030195254 Immediate release and stabilized formulation
10/16/2003US20030195253 Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
10/16/2003US20030195251 For therapy of psychiatric, pain and other disorders
10/16/2003US20030195250 Method for photodynamic therapy and applicator for carrying out said therapy
10/16/2003US20030195249 Crystal structured benzenesulfonic acid salts of 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol, used as sustained release antidepressants
10/16/2003US20030195248 Novel approach to anti-microbial host defense with molecular shields with lipoxin compounds
10/16/2003US20030195247 Antagonists of protein tryosin phosphatase 1B (PTP-1B) and T-cell protein tyrosine phosphatase (TC-PTP), used as antidiabetic agents and for prophylaxis of insulin resistance
10/16/2003US20030195246 Seamless soft capsule preparations containing dihydrobenzofuran derivatives
10/16/2003US20030195244 Nitrogen compounds such as (6-Methoxy-1H-indol-3-yl)-(3,4,5-trimethoxy-phenyl)-methanone, administered for prophylaxis of cancer; angiogenesis inhibitors
10/16/2003US20030195242 Administering preferential cyclooxygenase inhibitors such as celecoxib to prevent activation of DNA viruses
10/16/2003US20030195241 Mitogen-activated protein kinase inhibitors used for prophylaxis of cancer, inflammatory and cardiovascular disorders, and as coatings for medical equipments such as stents
10/16/2003US20030195240 Synergystic mixtures of proton pump inhibitors and nitrogen compounds such as 5-((2-adamantan-1-ylmethyl-5-phenyl-1H-pyrole-3-carbonyl)amino)-isophthalic acid, used for prophylaxis of gastrointerstinal disorders
10/16/2003US20030195239 Heterocyclic esters such as 6-cyclopentyl-6-(4-phenyl-but-3-ynyl)-dihydropyran-2,4-dione, used as enzyme inhibitors or for prophylaxis of virus infections
10/16/2003US20030195238 Enzyme inhibitors
10/16/2003US20030195237 Gastrin and cholecystokinin receptor lignads (iv)
10/16/2003US20030195236 Heterocyclic imines such as 2-methyl-3-toluoyloxy-4-formyl-5-hydroxymethylpyridine, used for prophylaxis of vitamin B6 deficiency, cardiovascular disorders or melanomas
10/16/2003US20030195235 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
10/16/2003US20030195234 Substituted oxindole derivatives as tyrosine kinase inhibitors
10/16/2003US20030195233 Carbocyclic secondary amides such as 2-(4-fluoro-phenoxy) -N-(4-((2-hydroxy-3-methyl-benzoyl amino)-methyl)-benzyl)-nicotinamide, administered for prophylaxis of respiratory system disorders
10/16/2003US20030195232 2,3-Disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
10/16/2003US20030195231 Heterocyclic sulfur compounds and/or prodrugs administered for prophylaxis of thrombocytopenia, anemia or blood disorders
10/16/2003US20030195230 Substituted amine derivatives and methods of use
10/16/2003US20030195229 Administering viricides such as N-nonenyl glucosamine, and optionally with mixtures of nucleosides, nucleotides, immunomodulators or immunostimulants for prophylaxis viral diseases
10/16/2003US20030195228 Pharmaceutical compositions for hepatitis C viral protease inhibitors
10/16/2003US20030195227 Retroviral protease inhibitors
10/16/2003US20030195226 Nitrogen compounds such as pyridine-3-carbaldehyde, O-(((4-undecyloxy-phenyl)amino)carbonyl)oxime, used for prophylaxis of vision, eating or cardiovascular disorders, and as anxiolytic and antiemetic agents
10/16/2003US20030195225 Acidification of drugs such as carbendazim, by mixing with buffers improving water solubility; anticarcinogenic agents
10/16/2003US20030195224 An immunomodulators, antitumor agents and induce cytokine biosynthesis, treating viral diseases
10/16/2003US20030195223 Antithrombotic agents
10/16/2003US20030195222 Substituted pyrimidinones and pyrimidinthiones
10/16/2003US20030195221 Substituted indolizine-like compounds and methods of use
10/16/2003US20030195220 Preparations for oral administration
10/16/2003US20030195219 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity
10/16/2003US20030195218 Treating hyperlipidemic condition, gallstones
10/16/2003US20030195216 Octahydro-2H-pyrido[1,2-a] pyrazine compounds
10/16/2003US20030195215 Compounds effective as beta-2 adrenoreceptor agonists as well pde4-inhibitors
10/16/2003US20030195214 Cancer treatment
10/16/2003US20030195213 A methylene-4-oxo-2-thionothiazolidin derivatives viricides for treating infections caused by Flavivirous
10/16/2003US20030195212 An amide derivatives for treating obesity, anorexia, inflammation, mental diseases associated with the melanocyte stimulating hormones
10/16/2003US20030195211 Inhibitors of human phosphatidylinositol 3-kinase delta
10/16/2003US20030195210 An enzyme inhibitors of cyclic guanosine 3',5'-monophophate-metabolizing phosphodiesterases; treating cardiovascular disorders, brian disorders, Alzheimer's disease, urogenital or sexual disorders
10/16/2003US20030195208 Phthalimido derivatives and a process for their preparation
10/16/2003US20030195206 An enzyme inhibitors, enzyme is to catalyse the hydrolysis of an ester; treating hyperlipaemia, hyperglycaemia (type II diabetes), hypertension, cardiovascular disorders stroke, gastrointestinal disease; chemical intermediate synthesis
10/16/2003US20030195204 Quinoline derivatives as NK3 antagonists
10/16/2003US20030195203 Heterocyclic derivatives
10/16/2003US20030195202 Inhibitors of IMPDH enzyme
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195200 Compounds, their preparation and use
10/16/2003US20030195199 Pancreatic lipase inhibitor compounds, their synthesis and use
10/16/2003US20030195198 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
10/16/2003US20030195197 Non-nucleoside reverse transcriptase inhibitors
10/16/2003US20030195196 Pyrrolobenzodiazepines
10/16/2003US20030195195 Substituted pyridines having antiangiogenic activity
10/16/2003US20030195194 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/16/2003US20030195193 Useful as activated blood coagulation factor X inhibitor; useful as an anticoagulant or an agent for prophylaxis and therapy of diseases caused by thrombus or embolus
10/16/2003US20030195192 Nicotinamides having antiangiogenic activity
10/16/2003US20030195191 N-sulfonyl hydroxamic acid derivatives as inhibitors of cd23
10/16/2003US20030195189 For therapy of hyperproliferative diseases
10/16/2003US20030195188 Pyridine and quinoline derivatives
10/16/2003US20030195186 Administration of a therapeutically effective amount of at least one acetylcholinesterase inhibitor
10/16/2003US20030195185 For therapy of cough, pain, anxiety, asthma, depression or alcohol abuse
10/16/2003US20030195184 Diagnosis and management of infection caused by chlamydia
10/16/2003US20030195183 Method for correcting immune system of live body
10/16/2003US20030195182 Triterpene derivatives and remedies for liver diseases
10/16/2003US20030195181 Laulimalide derivatives
10/16/2003US20030195180 Estrogenic compounds as anti-mitotic agents
10/16/2003US20030195179 Redispersibility comprising polyvinylpyrrolidone and a water-soluble anionic macromolecular compound which are added to prevent a hardly soluble drug from adhering to a container and forming aggregates
10/16/2003US20030195178 Kernel oil from plant kernel, process for extracting same, pharmaceutical composition and thereof
10/16/2003US20030195177 Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
10/16/2003US20030195175 Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
10/16/2003US20030195172 Novel phosphonic acid compounds as inhibitors of serine proteases
10/16/2003US20030195171 Method for inhibiting bone resorption with an alendronate and vitamin D formulation
10/16/2003US20030195170 Tablets for treatment of osteoporosis
10/16/2003US20030195169 Such as (S)-phosphoric acid mono-(3-(5-chloro-2-methoxy-phenyl)-3-fluoro-2-oxso-6-trifluoromethyl-2,3 -dihydro-indol-1-ylmethyl)ester; for modulation of large-conductance calcium-activated potassium (BK) channels
1 ... 5308 5309 5310 5311 5312 5313 5314 5315 5316 5317 5318 5319 5320 5321 5322 5323 5324 5325 5326 5327 5328 ... 7860